Literature DB >> 11122899

New style clinical trials in schizophrenia.

W T Carpenter1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11122899     DOI: 10.1007/s11920-999-0004-2

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  14 in total

1.  Psychopathology and common sense.

Authors:  W T Carpenter
Journal:  Biol Psychiatry       Date:  1991-04-15       Impact factor: 13.382

2.  Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.

Authors:  U Heresco-Levy; D C Javitt; M Ermilov; C Mordel; G Silipo; M Lichtenstein
Journal:  Arch Gen Psychiatry       Date:  1999-01

3.  Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

Authors:  R Rosenheck; L Dunn; M Peszke; J Cramer; W Xu; J Thomas; D Charney
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

4.  A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

Authors:  D C Goff; G Tsai; J Levitt; E Amico; D Manoach; D A Schoenfeld; D L Hayden; R McCarley; J T Coyle
Journal:  Arch Gen Psychiatry       Date:  1999-01

5.  Clozapine: is another view valid?

Authors:  H Y Meltzer
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

6.  Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.

Authors:  K Wahlbeck; M Cheine; A Essali; C Adams
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

7.  Amelioration of negative symptoms in schizophrenia by glycine.

Authors:  D C Javitt; I Zylberman; S R Zukin; U Heresco-Levy; J P Lindenmayer
Journal:  Am J Psychiatry       Date:  1994-08       Impact factor: 18.112

Review 8.  Patient response and resource management: another view of clozapine treatment of schizophrenia.

Authors:  W T Carpenter; R R Conley; R W Buchanan; A Breier; C A Tamminga
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

9.  Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

Authors:  R W Buchanan; A Breier; B Kirkpatrick; P Ball; W T Carpenter
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

10.  Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.

Authors:  D C Goff; G Tsai; D S Manoach; J T Coyle
Journal:  Am J Psychiatry       Date:  1995-08       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.